Glenview Capital Management, LLC Myriad Genetics Inc Transaction History
Glenview Capital Management, LLC
- $3.55 Billion
- Q2 2025
A detailed history of Glenview Capital Management, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Glenview Capital Management, LLC holds 4,587,407 shares of MYGN stock, worth $27.7 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
4,587,407
Previous 3,899,550
17.64%
Holding current value
$27.7 Million
Previous $34.6 Million
29.58%
% of portfolio
0.69%
Previous 0.85%
Shares
24 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
94.1MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.55MShares$27.5 Million0.0% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...